Sudden unexpected death with lamotrigine: risk estimate


REPORT FROM THE AMERICAN EPILEPSY SOCIETY 65TH ANNUAL MEETING, BALTIMORE, MD, DECEMBER 2-6, 2011 – A Norwegian study estimates that the risk of sudden unexpected death in epilepsy (SUDEP) is 2.5 per 1000 patient-years in female patients receiving lamotrigine compared to 0.5 per 1000 patient-years in women not on lamotrigine (Aurlien et al. AES 2011; abstract 3.205).

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page